A study of immune diversity in patients with adult-onset nephrotic syndrome (frequent relapses or steroid dependence)
Not Applicable
- Conditions
- Adult-onset nephrotic syndrome (frequent relapses or steroid-dependent)
- Registration Number
- JPRN-UMIN000041479
- Lead Sponsor
- Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with secondary nephrotic syndrom e (including suspicion) 2. Patients who have been treated with rituximab 3.Patients with eGFR of 44mL / min / 1.73m2 or less 4.Patients with an infectious disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gene diversity of T cell receptor (TCR) and B cell receptor (BCR)at baseline or their changes during treatment.
- Secondary Outcome Measures
Name Time Method Proportion of T cell subsets and B cell subsets at baseline or their changes during treatment. Search for biomarkers.